Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines

NCT06937944 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
669
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

JHM BioPharma (Tonghua) Co. , Ltd.